Cargando…

Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa

Detalles Bibliográficos
Autores principales:	Iannone, Michela, Janowska, Agata, Tonini, Giulia, Davini, Giulia, Dini, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	COVID-19: Important Updates and Developments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131181/ https://www.ncbi.nlm.nih.gov/pubmed/34809775 http://dx.doi.org/10.1016/j.clindermatol.2021.05.026

Ejemplares similares

A definite case of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) induced by administration of the Pfizer/BioNTech BNT162b2 vaccine for SARS-CoV2
por: Schroeder, Jan Walter, et al.
Publicado: (2022)

Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: The importance of a psychodermatological approach
por: Iannone, Michela, et al.
Publicado: (2022)

Pityriasis rosea, pityriasis rosea–like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination
por: Drago, Francesco, et al.
Publicado: (2022)

Ultrasound‐guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: A prospective study
por: Iannone, Michela, et al.
Publicado: (2021)

Self-reported measure of subjective distress in response to COVID-19 pandemic in patients referred to our skin cancer unit during the first wave
por: Borsari, Stefania, et al.
Publicado: (2022)

Dermatologic reactions to disinfectant use during the COVID-19 pandemic
por: Goh, Choon Fu, et al.
Publicado: (2021)

Addendum to: Eruption as a clinical manifestation of COVID-19: Photographs of a patient
por: Hoenig, Leonard J., et al.
Publicado: (2021)

Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2?
por: Lipsker, Dan
Publicado: (2020)

Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children
por: Brumfiel, Caitlin M., et al.
Publicado: (2021)

Cutaneous manifestations of COVID-19 in children (and adults): A virus that does not discriminate
por: Lavery, Michael Joseph, et al.
Publicado: (2021)

Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
por: Pi, Zixin, et al.
Publicado: (2020)

Changing gears: Medical gloves in the era of coronavirus disease 2019 pandemic
por: Anedda, Jasmine, et al.
Publicado: (2020)

Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases
por: Pawar, Manoj, et al.
Publicado: (2020)

Could injured skin be a reservoir for SARS-CoV-2 virus spread?
por: Elgarhy, Lamia Hamouda, et al.
Publicado: (2020)

A case for palliative dermatology: COVID-19–related dermatoses
por: Ho, Bernard, et al.
Publicado: (2020)

COVID toes or pernio?
por: Zaladonis, Angela, et al.
Publicado: (2020)

A dermatologic perspective on multisystem inflammatory syndrome in children
por: Naka, Fludiona, et al.
Publicado: (2021)

COVID-19 (SARS-CoV-2) infection presenting as acute urticaria
por: Farhan, Mariam, et al.
Publicado: (2021)

Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19
por: Galimberti, Fabrizio, et al.
Publicado: (2020)

Remdesivir: A giant step, or a tiptoe?
por: Dickinson, Gordon M.
Publicado: (2020)

Reply: Introducing special cutaneous “sign” tribute to health care workers managing new coronavirus disease (COVID-19)—new additions
por: Kannangara, Ajith P.
Publicado: (2021)

Impact of COVID-19 pandemic on the management of cutaneous lymphomas
por: Mateeva, Valeria, et al.
Publicado: (2021)

“Do-not-resuscitate (DNR)” status determines mortality in patients with COVID-19
por: Alhatem, Albert, et al.
Publicado: (2021)

In memoriam: Physicians who have died of COVID-19 in the United States
por: Hoenig, Leonard J.
Publicado: (2020)

Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
por: Mansouri, Parvin, et al.
Publicado: (2021)

Management of laser treatments during the coronavirus disease 2019 pandemic: The Italian experience
por: Bennardo, Luigi, et al.
Publicado: (2021)

Survey to evaluate the patient experience of virtual telephone consultations during the COVID-19 pandemic
por: Lavery, Michael Joseph, et al.
Publicado: (2021)

Impact of COVID-19 on medical practice: A nationwide survey of dermatologists and health care providers in Iraq
por: Shanshal, Mohammed, et al.
Publicado: (2021)

A dermatologic perspective on multisystem inflammatory syndrome in children
por: Naka, Fludiona, et al.
Publicado: (2021)

Clinicopathologic features between different viral epidemic outbreaks involving the skin
por: Atzori, Laura, et al.
Publicado: (2021)

Dermatopathology resident training and education during the COVID-19 pandemic: Challenges faced and lessons learned
por: Mahmood, Muhammad N.
Publicado: (2021)

Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis
por: Capoferri, Gioele, et al.
Publicado: (2022)

Clinicopathologic features among different viral epidemic outbreaks involving the skin
por: Atzori, Laura, et al.
Publicado: (2022)

Cutaneous adverse effects of the available COVID-19 vaccines
por: Bogdanov, Georgi, et al.
Publicado: (2021)

COVID-19: The Italian experience
por: Musumeci, Maria Letizia, et al.
Publicado: (2021)

Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals
por: Ramirez-Quizon, Mae, et al.
Publicado: (2021)

COVID-19–related skin manifestations: Update on therapy
por: Atzori, Laura, et al.
Publicado: (2021)

COVID-19 and Dermatology in Iran
por: Mansouri, Parvin, et al.
Publicado: (2021)

Impact of COVID-19 on patients with atopic dermatitis
por: Grieco, Teresa, et al.
Publicado: (2021)

The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy
por: Gualdi, Giulio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0op9pfnlef5v6fpv7crnto0ro1